John Trainer serves as Executive at NexImmune, Inc., where they oversee executive responsibilities. Since joining the company, John Trainer has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 22, 2022 involved receiving (via award) 125,200 shares valued at $0.
John Trainer currently holds 186,969 shares of NexImmune, Inc. (NEXI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Trainer has been a net neutral trader of NEXI stock. They have purchased $0 and sold $0 worth of shares.
John Trainer's most recent insider trade was on Nov 22, 2022, when they sold 125,200 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $5.17 |
| Discretionary |
| Jun 8, 2021 | NEXI | $17.7K | Option Exercise | 3,432 | $5.17 | Discretionary |
| May 8, 2021 | NEXI | $17.7K | Option Exercise | 3,432 | $5.17 | Discretionary |
| Apr 8, 2021 | NEXI | $17.7K | Option Exercise | 3,432 | $5.17 | Discretionary |
| Mar 10, 2021 | NEXI | $17.7K | Option Exercise | 3,432 | $5.17 | Discretionary |